Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
نویسندگان
چکیده
منابع مشابه
Hepatitis C Virus Late Relapse after Sustained Virologic Response
24 Hepatitis C (HCV) viremia is unusual (<5%) after successful treatment, defined as sustained 25 virologic response (SVR) or undetectable HCV PCR 12-24 weeks after therapy. We present a 26 case of late virologic relapse (de novo infection excluded by RNA sequencing) after SVR 27 followed by spontaneous viral clearance. 28
متن کاملRisk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection.
UNLABELLED The long-term prognosis in terms of risk or predictors of developing hepatocellular carcinoma (HCC) among patients with sustained virological response (SVR) remains unclear. We conducted a retrospective cohort study using data from the Veterans Affairs VA hepatitis C virus (HCV) Clinical Case Registry in patients with positive HCV RNA between October 1999 and August 2009 and follow-u...
متن کاملRisk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV
Background Highly effective hepatitis C virus (HCV) therapies have spurred a scale-up of treatment to populations at greater risk of reinfection after sustained virologic response (SVR). Reinfection may be higher in HIV-HCV coinfection, but prior studies have considered small selected populations. We assessed risk factors for reinfection after SVR in a representative cohort of Canadian coinfect...
متن کاملRisk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response
The recent development of interferon-free direct-acting antivirals (DAAs) has had a significant impact on the already great advances made in the treatment of hepatitis C. Combination therapy with pegylated interferon, ribavirin and simeprevir has achieved a sustained virological response (SVR) rate of approximately 70% in patients with hepatitis C caused by the genotype Ib virus. Combination th...
متن کاملRisk of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Who Achieved Sustained Virological Response
The recent development of interferon-free direct-acting antivirals (DAAs) has had a significant impact on the already great advances made in the treatment of hepatitis C. Combination therapy with pegylated interferon, ribavirin and simeprevir has achieved a sustained virological response (SVR) rate of approximately 70% in patients with hepatitis C caused by the genotype Ib virus. Combination th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Journal of Hepatology
سال: 2018
ISSN: 1948-5182
DOI: 10.4254/wjh.v10.i12.898